BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.920
-0.040 (-1.35%)
At close: Apr 1, 2025, 4:00 PM
3.026
+0.106 (3.61%)
After-hours: Apr 1, 2025, 4:51 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $11.50 million as of April 1, 2025. Its market cap has decreased by -87.40% in one year.
Market Cap
11.50M
Enterprise Value
7.03M
1-Year Change
-87.40%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $11.50M, a decrease of -65.99%. That is a compound annual growth rate of -6.64%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.27B |
| UnitedHealth Group | 478.13B |
| Johnson & Johnson | 398.83B |
| AbbVie | 366.44B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 228.74B |
| Merck & Co. | 225.02B |